Johnson & Johnson
Compare market positioning with top industry peers
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
Financial Performance
Revenue
$94.2B
Market Cap
$382.4B
Net Income
$26.8B
Employees
131,900
Johnson & Johnson is operating as a streamlined, pure-play pharmaceutical and med-tech powerhouse following the complete spin-off of its consumer health division (Kenvue). Under CEO Joaquin Duato, the healthcare giant generated exactly $85.1 billion in revenue and maintains a $382.4 billion market cap with exactly 131900 employees. The financial narrative in 2026 is entirely defined by aggressive oncology acquisitions; desperately racing to replace revenue losses from the impending patent cliff of Stelara, J&J is deploying unprecedented billions to acquire promising antibody-drug conjugates.
Revenue Trend Analysis
YoY Change
+6%
2-Year CAGR
+5.2%
Peak Year
2025
Trend
Consistent Growth
Johnson & Johnson has reported revenue across 3 fiscal years, compounding at +5.2% annually over 2 years. The most recent year saw a 6% increase versus the prior year. Revenue peaked in 2025 at $94.2B. Out of 2 reported periods, 2 showed growth and 0 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $94.2B | $26.8B | +6.0% |
| FY2024 | $88.8B | $14.1B | +4.3% |
| FY2023 | $85.2B | $35.2B | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
Johnson & Johnson reported approximately $85.1B in fiscal year 2025 with a team of 131,900 employees worldwide.
Johnson & Johnson strategically balances reinvestment into core R&D with operational cost discipline, focusing on workflow automation to expand operating margins in 2026.
Financial performance in Healthcare and Pharmaceuticals is driven by steady cash generation and pricing power, enabling Johnson & Johnson to reinvest in high-return strategic initiatives.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "Johnson & Johnson Revenue & Financials." CorpDigest, https://corpdigest.com/company/johnson-and-johnson/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>Johnson & Johnson reported $94B in revenue (FY2025).</strong><br>Source: <a href="https://corpdigest.com/company/johnson-and-johnson/financials" target="_blank" rel="noopener">CorpDigest — Johnson & Johnson financials</a></div>